Skip to content
Tuesday 18 August 2026London --:--Frankfurt --:--Zurich --:--
NewslettersSearchEN · DE · FR
MorningWire

European business, markets and politics

FTSE 100
10,728.04
+0.07%
DAX
26,128.36
-0.80%
CAC 40
8,509.36
-0.82%
STOXX 50
6,468.17
-0.95%
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
More
GermanyFranceEU InstitutionsCompetitionPublic AffairsBankingTechnologyEnergy
  • Germany
  • France
  • Europe
  • Markets
  • Business
  • Economy
  • Regulation
  • Politics
  • Opinion
  • DE
Saturday 10 February 2024 1:07 pm

Pfizer/BioNTech Covid jab to be sold in UK high street pharmacies

By: Morning Wire reporter

Add as a preferred source on Google
The Pfizer/BioNTech Covid jab will be sold in UK high street pharmacies from next month.
The Pfizer/BioNTech Covid jab will be sold in UK high street pharmacies from next month.

The Pfizer/BioNTech Covid jab will be sold in UK high street pharmacies from next month.

Pharmaceutical giant Pfizer is in talks with major pharmacy chains, such as Boots, to sell the vaccine to people who cannot get one on the NHS.

The price will be set by individual pharmacies – much in the way prices are currently set for annual flu jabs.

The vaccine, which is suitable for people aged 12 and over, will also be available from private health firms.

Dr Gillian Ellsbury, primary care medical director at Pfizer UK, said: “Covid-19 has not gone away and continues to be a threat.

“As we move from a pandemic to an endemic state, we need to ensure we remain ready to respond to this constantly evolving and unpredictable virus.

“Vaccines remain an important pillar in helping to prevent serious illness or hospitalisation as a result of Covid-19.

Read more

Fine dining and The Jab: A Michelin dinner with the Ozempic set

Ozempic tablet on a plate highlighting medications role in weight loss and diabetes management in healthcare news.

“By enabling the wider availability of the Pfizer-BioNTech Covid-19 vaccine we are facilitating choice and access for those that are not eligible to receive it through the NHS programme, but want the option of a Covid-19 vaccine.”

A spokeswoman for Moderna said it was looking to supply Covid-19 vaccines to healthcare providers for private sales in time for autumn 2024.

On Thursday, the Joint Committee on Vaccination and Immunisation (JCVI), which advises the UK government on vaccines for the NHS, released details of who is eligible for a spring Covid booster.

It has said the jabs should be given on the NHS to adults aged 75 years and over, care home residents and anyone aged six months or over who is immunosuppressed.

The move differs from arrangements for the autumn 2023 booster, which was for all adults aged 65 and over to get the jab, alongside care home residents and the immunosuppressed.

Press Association – Jane Kirby

Read more

ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

Share this article

  • Facebook
  • X
  • LinkedIn
  • WhatsApp
  • Email

Similarly tagged content:

Sections

  • News

Categories

  • Politics

Related Topics

  • Coronavirus
  • Covid
  • Covid-19 a year on
  • Health
  • NHS
  • Pharmaceuticals
  • UK Government

Trending Articles

  • As it happened: FTSE 100 drops as oil prices rise after Trump makes Hormuz threat

  • US bond market jitters spark UK economy recession warning

  • Jobless Banquet: Youth unemployment surge ‘sends Neets to KFC’

  • Monzo chair makes early exit after boardroom rift

  • Aldi boss wades into supermarket ‘price-gouging’ row

More from Morning Wire

  • Fine dining and The Jab: A Michelin dinner with the Ozempic set

    Life&Style
    Ozempic tablet on a plate highlighting medications role in weight loss and diabetes management in healthcare news.
  • ILiAD Biotechnologies Expands Board of Directors and Appoints Chief Business Officer

    Business Wire
  • This Is the Moment Everything Changed: Ascensia Launches Global Art and Photography Competition for World Diabetes Day

    Business Wire
  • Back to basics: Sainsbury’s gradual retreat from the British high street

    Retail
    Sainsbury’s Cobham. Credit: David Parry/PA Media Assignments.
  • Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma

    Business Wire
  • Brits dodge the high street as heatwave boosts online shopping

    Retail
    Shoppers carrying various retail bags, including New Look and M&S Food, on a paved street, indicating retail sales activity.
  • Victory wasted: The cautionary tale of Keir Starmer

    Opinion
    Keir Starmer exiting a building, dressed in a suit, amid media attention, reflecting leadership and political significance
  • Verdiva Bio Appoints Cardiometabolic Leader Steve Marso as Chief Medical Officer

    Business Wire
MorningWire

Independent European business, markets and political news for decision-makers.

Morning Briefing

Europe

  • Germany
  • France
  • EU Institutions
  • Europe

Business

  • Markets
  • Business
  • Economy
  • Regulation
  • Competition
  • Public Affairs

Editorial

  • Opinion
  • Editorial Policy
  • Corrections
  • Contact

Company

  • About Morning Wire
  • Privacy Policy
  • Terms of Use
  • Cookie Policy
© 2026 Morning Wire Ltd · Published by Morning Wire Media, Bahnhofstrasse 65, 8001 Zürich, Switzerland
Privacy · Terms · Cookies · Facebook